Understanding how tuberculosis affects blood sugar and metabolism
Multiomics Characterization of Micobiome and Immunometabolic REmodeling in Tuberculosis Stress Hyperglycemia
This study is looking at how having tuberculosis might affect your blood sugar and increase the risk of diabetes over time, and it's for people who have had tuberculosis and want to understand how it could impact their health after treatment.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11064045 on NIH RePORTER |
What this research studies
This research investigates the long-term effects of tuberculosis on metabolic health, particularly focusing on how it can lead to stress hyperglycemia and increase the risk of diabetes. By studying a unique group of patients from Georgia, the research aims to track changes in blood sugar levels and metabolic health over 18 months during and after tuberculosis treatment. The goal is to uncover the mechanisms behind these changes to develop new therapies that can improve health outcomes for individuals affected by tuberculosis.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have been diagnosed with tuberculosis and are experiencing or at risk for stress hyperglycemia.
Not a fit: Patients who do not have a history of tuberculosis or related metabolic issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve metabolic health and reduce mortality in patients recovering from tuberculosis.
How similar studies have performed: Previous research has shown promising results in understanding the relationship between tuberculosis and metabolic health, indicating that this approach has potential for significant insights.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Collins, Jeffrey M — Emory University
- Study coordinator: Collins, Jeffrey M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.